Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This research study will evaluate inter-individual variability in the analgesic response to
the non-steroidal anti-inflammatory drug (NSAID) ibuprofen after third molar extraction
surgery. It will also investigate demographic, clinical, genetic, and environmental factors
that cause this variability.